This Day On The Street
Continue to site right-arrow
This account is pending registration confirmation. Please click on the link within the confirmation email previously sent you to complete registration.
Need a new registration confirmation email? Click here
TheStreet Open House

Neogen Grows in Recession: Under the Radar

"Under the Radar" uncovers little-known companies worthy of investors' consideration. Check in at 5 every Monday, Wednesday and Friday morning to find out about stocks that tend to beat their bigger brethren.

LANSING, Mich. ( TheStreet) -- When a company achieves the rare feat of boosting revenue in a weak economy, it's a testament to the relevance of its products and the value of its shares. Here's a financially sound small-cap stock that deserves consideration.

Lansing, Mich.-based Neogen (NEOG - Get Report) makes diagnostic tests that detect dangerous substances in human food and animal feed. Our culture of consumer protection, which has made companies more liable in contamination situations, has spurred Neogen's aggressive expansion. Founded in 1982, the company now offers 200 diagnostic tests worldwide.

Neogen's revenue has grown 18% annually, on average, in the past three years. Its net income has climbed 26%, on average, during that period. The company has boosted earnings for 20 straight quarters. This cyclical resilience benefits shareholders. Neogen's stock has advanced 13% over the past year as the Russell 2000 Index, a small-cap barometer, dropped 20%.

Fiscal fourth-quarter net income rose 8% to $3.4 million, or 22 cents a share, as revenue increased 14% to $31 million. Although its gross margin declined from 55% to 54%, its operating margin rose from 17% to 18% as expenses as a percentage of revenue declined.

Of Neogen's two business segments, animal safety posted the larger sales increase in the quarter. The company purchased a line of disinfectants and cleansers from DuPont (DD - Get Report) in spring 2008, which accounted for most of the company's revenue growth. Sales of pre-existing products also jumped 6%.

Neogen has an outstanding financial position. Its balance sheet holds $14 million of cash reserves, amounting to a quick ratio of 4. And the company has financed itself entirely with equity, so it has no debt. We give Neogen a financial strength score of 7.9 out of 10, higher than the "buy"-list average of 7.1.

1 of 2

Check Out Our Best Services for Investors

Action Alerts PLUS

Portfolio Manager Jim Cramer and Director of Research Jack Mohr reveal their investment tactics while giving advanced notice before every trade.

Product Features:
  • $2.5+ million portfolio
  • Large-cap and dividend focus
  • Intraday trade alerts from Cramer
Quant Ratings

Access the tool that DOMINATES the Russell 2000 and the S&P 500.

Product Features:
  • Buy, hold, or sell recommendations for over 4,300 stocks
  • Unlimited research reports on your favorite stocks
  • A custom stock screener
Stocks Under $10

David Peltier uncovers low dollar stocks with serious upside potential that are flying under Wall Street's radar.

Product Features:
  • Model portfolio
  • Stocks trading below $10
  • Intraday trade alerts
14-Days Free
Try it NOW
Only $9.95
Try it NOW
14-Days Free
Try it NOW

Check Out Our Best Services for Investors

Dividend Stock Advisor

David Peltier identifies the best of breed dividend stocks that will pay a reliable AND significant income stream.

Product Features:
  • Diversified model portfolio of dividend stocks
  • Updates with exact steps to take - BUY, HOLD, SELL
Trifecta Stocks

Every recommendation goes through 3 layers of intense scrutiny—quantitative, fundamental and technical analysis—to maximize profit potential and minimize risk.

Product Features:
  • Model Portfolio
  • Intra Day Trade alerts
  • Access to Quant Ratings
Options Profits

Our options trading pros provide over 100 monthly option trading ideas and strategies to help you become a well-seasoned trader.

Product Features:
  • Actionable options commentary and news
  • Real-time trading community
Try it NOW
Try it NOW
Try it NOW
To begin commenting right away, you can log in below using your Disqus, Facebook, Twitter, OpenID or Yahoo login credentials. Alternatively, you can post a comment as a "guest" just by entering an email address. Your use of the commenting tool is subject to multiple terms of service/use and privacy policies - see here for more details.
Submit an article to us!
DD $72.58 1.30%
NEOG $47.24 0.47%
AAPL $126.37 2.53%
FB $83.20 -0.13%
GOOG $552.03 0.67%


DOW 17,976.31 +263.65 1.49%
S&P 500 2,086.24 +25.22 1.22%
NASDAQ 4,947.4410 +56.2220 1.15%

Partners Compare Online Brokers

Free Reports

Free Newsletters from TheStreet

My Subscriptions:

After the Bell

Before the Bell

Booyah! Newsletter

Midday Bell

TheStreet Top 10 Stories

Winners & Losers

Register for Newsletters
Top Rated Stocks Top Rated Funds Top Rated ETFs